Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Neurological effects of encapsulated dexamethasone sodium phosphate in children aged 6-9 years with ataxia telangiectasia (NEAT): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Child & adolescent health
Published: March 11, 2026
Use of encapsulated dexamethasone sodium phosphate (eDSP) in chronic obstructive pulmonary disease, cystic fibrosis, and inflammatory bowel disorders.
Journal: Frontiers in drug delivery
Published: October 22, 2025
Walking Capacity in Children With Ataxia Telangiectasia From the Global Ataxia Telangiectasia Family Data Platform.
Journal: Annals of the Child Neurology Society
Published: July 10, 2025
The ATTeST trial in ataxia telangiectasia: some concerns - Authors' response.
Journal: The Lancet. Neurology
Published: January 14, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia.
Journal: Frontiers in neurology
Published: November 12, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
Journal: The Lancet. Neurology
Published: January 26, 2024
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.
Journal: Antimicrobial agents and chemotherapy
Published: July 29, 2016
Efficacy of ceftaroline fosamil for bacteremia associated with community-acquired bacterial pneumonia.
Journal: Hospital practice (1995)
Published: February 26, 2014
Prospective study of the Wilson severity-of-illness scoring system for complicated skin and skin structure infections.
Journal: Antimicrobial agents and chemotherapy
Published: November 07, 2012
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
Journal: Antimicrobial agents and chemotherapy
Published: February 09, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026